New CMS Codes Issued to Spark Biomedical for Transcutaneous Auricular Neurostimulation (tAN®) Therapy Using Sparrow Ascent
Spark Biomedical, Inc., a leader in non-invasive neurostimulation technology, has received two unique Healthcare Common Procedure Coding System (HCPCS) codes from the Centers for Medicare and Medicaid Services (CMS). These codes are for their Sparrow® Ascent, the first FDA-cleared non-invasive neurostimulation device for opioid withdrawal treatment using transcutaneous auricular neurostimulation (tAN®) therapy, as well as its daily-disposable Earpiece Kit. This achievement is a significant milestone in obtaining insurance coverage, helping to make this innovative treatment more accessible to individuals with opioid use disorder nationwide.
New CMS Codes Issued to Spark Biomedical for Transcutaneous Auricular Neurostimulation (tAN®) Therapy Using Sparrow Ascent